Iron supplementation group (N = 15) | NYT group (N = 15) | P value | ||
---|---|---|---|---|
Age-years | 45.1 ± 7.7 | 41.1 ± 8.3 | 0.52 | |
Body mass index-kg/m2 | 21.4 ± 2.6 | 22.6 ± 2.7 | 0.27 | |
Duration of intervention (IQR)-days | 39.7 ± 23.0 (23, 50) | 39.9 ± 20.3 (21, 58) | 0.88 | |
Disease-N (%) | 1 | |||
Benign | 10 (67) | 11 (73) | ||
Malignant | 5 (33) | 4 (27) | ||
Length of surgery-min | 221 ± 158 | 190 ± 152 | 0.76 | |
Menstruation-N (%) | 1 | |||
+ | 14 (93) | 15 (100) | ||
− | 1 (7) | 0 (0) | ||
Hormonal therapy-N (%) | 0.68 | |||
+ | 5 (33) | 3 (20) | ||
− | 10 (67) | 12 (80) | ||
Hemoglobin-g/dL | 9.9 ± 0.8 | 9.8 ± 1.0 | 0.59 | |
Hematocrit-% | 32.3 ± 2.1 | 32.7 ± 2.1 | 0.77 | |
Median serum iron level (IQR)-µg/dL | 27 (14, 84) $ | 32 (15, 146) # | 0.88 | |
Median ferritin (IQR)-ng/mL | 10 (5, 22) $ | 4 (3, 10) # | 0.18 | |
CFS | ||||
Physical | 5.9 ± 5.1 | 7.1 ± 5.4 | 0.4 | |
Affective | 6.5 ± 3.0 | 7.9 ± 4.1 | 0.38 | |
Cognitive | 3.5 ± 3.7 | 2.8 ± 2.8 | 0.92 | |
Total | 15.9 ± 9.3 | 17.9 ± 10.2 | 0.66 | |
Median VAS-A (IQR)-mm | 50 (8, 65) | 56 (50, 70) | 0.38 | |
Median PSQI (IQR) | 4 (3, 5) | 5 (3, 7) | 0.37 |